LEGAL DISCLAIMERS
PapiVax Biotech, Inc., has made the statements in these materials as of the date hereof unless it is stated otherwise. Neither the delivery of these materials, nor any sale of securities by PapiVax Biotech, Inc., after the date of these materials, shall create any implication that the information contained herein or the affairs of PapiVax Biotech, Inc., have not changed since the date hereof or that such information is correct as of any time subsequent to its date.
Management based all estimates and projections as to events that may occur in the future (including projections of market size/revenue, development plans and timing of clinical trial results) upon their research, assumptions discussed throughout this Business Plan, and best judgment as of the date of these materials. Whether or not such estimates or projections may be achieved will depend upon the company achieving its overall business objectives and the availability of funds, including funds from the sale of the securities in future financings that are not yet scheduled or even contemplated. PapiVax Biotech, Inc., does not guarantee that any of these projections will be attained. Actual results will vary from the projections, and such variations may be material.
This Business Plan is merely intended to provide interested parties with updated information regarding PapiVax Biotech, Inc., and its plans for the future. There is no guarantee that PapiVax Biotech, Inc., will make an offering in the future.